# Leaders Free Japan

> **NCT02348021** · PHASE3 · UNKNOWN · sponsor: **Biosensors Europe SA** · enrollment: 139 (estimated)

## Conditions studied

- Coronary Disease

## Interventions

- **PROCEDURE:** Percutaneous coronary intervention (PCI)
- **DRUG:** Dual Anti Platelet Therapy

## Key facts

- **NCT ID:** NCT02348021
- **Lead sponsor:** Biosensors Europe SA
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-07
- **Primary completion:** 2016-04
- **Final completion:** 2017-07
- **Target enrollment:** 139 (ESTIMATED)
- **Last updated:** 2015-09-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02348021

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02348021, "Leaders Free Japan". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02348021. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*